다우존스 지수

실시간 차트, 분석 도구 및 가격을 받으려면 등록하세요.

등록

홈
인베스팅
주식
미국
NASDAQ
LAVA Therapeutics NV (LVTX)
LAVA Therapeutics NV (LVTX) 뉴스

LVTX

LAVA Therapeutics NV (LVTX)

LAVA Therapeutics NV

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:LVTX

1 2 3 4 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2024/01/25	22:07	Dow Jones News	Lava Therapeutics Shares Rise as Drug Set for Test With Merck's Keytruda	NASDAQ:LVTX	LAVA Therapeutics NV
2023/11/17	06:05	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:LVTX	LAVA Therapeutics NV
2023/09/06	20:11	GlobeNewswire Inc.	LAVA Therapeutics to Participate in the H.C. Wainwright 25th Annual Global Investment Conference	NASDAQ:LVTX	LAVA Therapeutics NV
2023/08/23	05:05	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:LVTX	LAVA Therapeutics NV
2023/08/22	20:00	GlobeNewswire Inc.	LAVA Therapeutics Provides Business Update and Reports Second Quarter 2023 Financial Results	NASDAQ:LVTX	LAVA Therapeutics NV
2023/08/15	19:30	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:LVTX	LAVA Therapeutics NV
2023/08/14	20:00	GlobeNewswire Inc.	LAVA Therapeutics to Participate in the H.C. Wainwright Immune Cell Engager Virtual Conference	NASDAQ:LVTX	LAVA Therapeutics NV
2023/06/16	05:51	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	NASDAQ:LVTX	LAVA Therapeutics NV
2023/06/14	22:00	GlobeNewswire Inc.	LAVA Therapeutics Provides Updates on Clinical Programs and Extends the Cash Runway	NASDAQ:LVTX	LAVA Therapeutics NV
2023/06/09	05:06	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	NASDAQ:LVTX	LAVA Therapeutics NV
2023/06/08	20:00	GlobeNewswire Inc.	LAVA Therapeutics Provides Business Update and Reports First Quarter 2023 Financial Results	NASDAQ:LVTX	LAVA Therapeutics NV
2023/06/06	19:02	Edgar (US Regulatory)	Amended Statement of Beneficial Ownership (sc 13d/a)	NASDAQ:LVTX	LAVA Therapeutics NV
2023/06/06	07:31	Edgar (US Regulatory)	Report of Proposed Sale of Securities (144)	NASDAQ:LVTX	LAVA Therapeutics NV
2023/06/02	08:38	Dow Jones News	Stocks to Watch: Lululemon, Lava Therapeutics, Tilly's, Oncorus	NASDAQ:LVTX	LAVA Therapeutics NV
2023/06/02	05:20	GlobeNewswire Inc.	LAVA Therapeutics Announces Selection by Janssen of Lead Gamma-Delta T-Cell Engager Bispecific Antibody to Move Toward Clinical Development	NASDAQ:LVTX	LAVA Therapeutics NV
2023/06/01	21:09	GlobeNewswire Inc.	LAVA Therapeutics to Participate in the Jefferies Healthcare Conference	NASDAQ:LVTX	LAVA Therapeutics NV
2023/05/31	06:28	GlobeNewswire Inc.	LAVA Announces Annual Meeting of Shareholders	NASDAQ:LVTX	LAVA Therapeutics NV
2023/04/25	05:07	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	NASDAQ:LVTX	LAVA Therapeutics NV
2023/04/12	19:03	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	NASDAQ:LVTX	LAVA Therapeutics NV
2023/04/11	20:00	GlobeNewswire Inc.	LAVA Therapeutics Provides Business Update and Reports Fourth Quarter and Year-End 2022 Financial Results	NASDAQ:LVTX	LAVA Therapeutics NV
2023/03/09	22:05	GlobeNewswire Inc.	LAVA Therapeutics Announces Appointment of Christy J. Oliger to its Board of Directors	NASDAQ:LVTX	LAVA Therapeutics NV
2023/02/16	21:06	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	NASDAQ:LVTX	LAVA Therapeutics NV
2023/02/16	21:00	GlobeNewswire Inc.	LAVA Therapeutics Announces Initial Data from the Ongoing Phase 1/2a Clinical Trial of LAVA-1207 in Therapy Refractory mCRPC at the 2023 ASCO GU Symposium	NASDAQ:LVTX	LAVA Therapeutics NV
2023/02/09	21:00	GlobeNewswire Inc.	LAVA Therapeutics to Present at the 2023 SVB Securities Global Biopharma Conference	NASDAQ:LVTX	LAVA Therapeutics NV
2023/02/06	21:07	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	NASDAQ:LVTX	LAVA Therapeutics NV
2023/02/06	21:00	GlobeNewswire Inc.	LAVA Therapeutics Announces the Appointment of Dr. Charles Morris as Chief Medical Officer	NASDAQ:LVTX	LAVA Therapeutics NV
2023/01/23	21:00	GlobeNewswire Inc.	LAVA Therapeutics to Present LAVA-1207 Clinical Data at the 2023 ASCO GU Symposium	NASDAQ:LVTX	LAVA Therapeutics NV
2023/01/07	03:07	GlobeNewswire Inc.	LAVA Therapeutics Announces Appointment of New Directors to the Board	NASDAQ:LVTX	LAVA Therapeutics NV
2023/01/03	21:00	GlobeNewswire Inc.	LAVA Therapeutics to Present at the 41st Annual J.P. Morgan Healthcare Conference	NASDAQ:LVTX	LAVA Therapeutics NV
2022/12/24	06:02	Edgar (US Regulatory)	Amended Annual and Transition Report (foreign Private Issuer) (20-f/a)	NASDAQ:LVTX	LAVA Therapeutics NV

검색 관련기사 보기:NASDAQ:LVTX

1 2 3 4 다음 >>

US Dollar vs Yen

JP Morgan Chase

Verizon Communications

US Dollar vs Euro

Financial Select Sector

Invesco QQQ Trust Series 1

Delayed Upgrade Clock

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관